14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ZNTL stock ended at $11.71. This is 5.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.76% from a day low at $11.45 to a day high of $12.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jun 12, 2023 $23.80 $24.84 $23.51 $24.13 774 949
Jun 09, 2023 $24.21 $24.75 $23.35 $23.43 670 948
Jun 08, 2023 $24.23 $24.44 $23.10 $24.23 1 170 645
Jun 07, 2023 $25.25 $25.61 $24.00 $24.26 944 668
Jun 06, 2023 $25.50 $26.00 $23.98 $25.14 2 145 902
Jun 05, 2023 $26.14 $26.69 $23.45 $24.68 1 553 156
Jun 02, 2023 $26.06 $26.39 $25.61 $26.27 1 094 426
Jun 01, 2023 $25.95 $26.19 $25.23 $25.74 1 055 001
May 31, 2023 $26.56 $27.05 $25.91 $26.04 1 335 883
May 30, 2023 $31.46 $31.46 $26.36 $26.46 1 915 180
May 26, 2023 $29.93 $30.10 $24.02 $30.05 4 525 622
May 25, 2023 $26.54 $28.05 $26.05 $27.16 2 041 770
May 24, 2023 $26.49 $26.84 $25.68 $26.60 1 281 210
May 23, 2023 $27.44 $27.45 $25.75 $26.74 880 502
May 22, 2023 $26.35 $27.53 $26.21 $27.30 986 468
May 19, 2023 $26.94 $26.99 $25.82 $26.35 937 637
May 18, 2023 $26.64 $27.15 $25.93 $26.69 863 086
May 17, 2023 $27.66 $27.83 $26.00 $26.61 729 535
May 16, 2023 $27.41 $27.89 $26.58 $27.66 706 560
May 15, 2023 $27.06 $28.49 $26.87 $28.02 634 212
May 12, 2023 $26.28 $27.17 $25.84 $26.89 623 127
May 11, 2023 $24.32 $26.34 $24.07 $26.12 1 101 098
May 10, 2023 $23.40 $24.45 $23.02 $24.39 1 142 517
May 09, 2023 $21.59 $23.13 $21.44 $22.81 742 990
May 08, 2023 $22.55 $22.55 $20.97 $21.86 757 623
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT